The prevention of glucocorticoid‐induced osteoporosis in patients with immune thrombocytopenia receiving steroids: a British Society for Haematology Good Practice Paper-Reference-Cited by-同舟云学术

The prevention of glucocorticoid‐induced osteoporosis in patients with immune thrombocytopenia receiving steroids: a British Society for Haematology Good Practice Paper

Published:2019-01-04 Issue:3 Volume:185 Page:410-417
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Hill Quentin A.¹^ORCID,Grainger John D.²³,Thachil Jecko⁴,Provan Drew⁵,Evans Gillian⁶,Garg Mamta⁷,Bradbury Charlotte⁸⁹,Bagot Catherine¹⁰,Kanis John A.¹¹¹²,Compston Juliet E.¹³,

Affiliation:

1. Department of Haematology Leeds Teaching Hospitals Leeds UK

2. Royal Manchester Children's Hospital Manchester University Hospitals NHS Foundation Trust Manchester Academic Health Science Centre Manchester UK

3. Faculty of Medical & Human Sciences University of Manchester Manchester UK

4. Department of Haematology Manchester Royal Infirmary Manchester UK

5. Department of Haematology Barts& The London School of Medicine & Dentistry London UK

6. Department of Haematology Kent and Canterbury Hospital Canterbury UK

7. Department of Haematology Leicester Royal Infirmary Leicester UK

8. University Hospitals Bristol NHS Foundation Trust Bristol UK

9. Department of Cellular and Molecular Medicine University of Bristol Bristol UK

10. Department of Haematology Glasgow Royal Infirmary Glasgow UK

11. Centre for Metabolic Bone Diseases University of Sheffield Medical School Sheffield UK

12. Institute for Health and Ageing Australian Catholic University Melbourne Australia

13. Department of Medicine Addenbrooke's Hospital Cambridge UK

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.15735

Reference43 articles.

1. Fracture risk in oral glucocorticoid users: a Bayesian meta-regression leveraging control arms of osteoporosis clinical trials

2. Effectiveness of Oral Bisphosphonates in Reducing Fracture Risk Among Oral Glucocorticoid Users: Three Matched Cohort Analyses

3. The role of vitamin D in corticosteroid-induced osteoporosis: A meta-analytic approach

4. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures

5. Once-Yearly Zoledronic Acid for Treatment of Postmenopausal Osteoporosis

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Longitudinal evaluation of adverse events due to steroid use in primary immune thrombocytopenia: A population‐based study;British Journal of Haematology;2024-03-04

2. The Outcomes and Adverse Drug Patterns of Immunomodulators and Thrombopoietin Receptor Agonists in Primary Immune Thrombocytopenia Egyptian Patients with Hemorrhage Comorbidity;Pharmaceuticals;2023-06-12

3. Bisphosphonate use for glucocorticoid-induced osteoporosis in older patients with immune thrombocytopenia: a clinical perspective;Annals of Hematology;2023-05-12

4. Expert Report on Immune Thrombocytopenia: Current Diagnostics and Treatment – Recommendations from an Expert Group from Austria, Germany, and Switzerland;Oncology Research and Treatment;2023

5. Expertenreport Immunthrombozytopenie – Aktuelle Diagnostik und Therapie;Oncology Research and Treatment;2022-12-26